KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Total Current Liabilities (2017 - 2025)

Cardlytics (CDLX) has disclosed Total Current Liabilities for 9 consecutive years, with $78.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities fell 47.37% year-over-year to $78.4 million, compared with a TTM value of $78.4 million through Dec 2025, down 47.37%, and an annual FY2025 reading of $78.4 million, down 47.37% over the prior year.
  • Total Current Liabilities was $78.4 million for Q4 2025 at Cardlytics, down from $123.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $327.3 million in Q4 2021 and bottomed at $78.4 million in Q4 2025.
  • Average Total Current Liabilities over 5 years is $184.3 million, with a median of $169.5 million recorded in 2023.
  • The sharpest move saw Total Current Liabilities skyrocketed 519.34% in 2021, then crashed 47.37% in 2025.
  • Year by year, Total Current Liabilities stood at $327.3 million in 2021, then fell by 23.95% to $248.9 million in 2022, then tumbled by 31.25% to $171.1 million in 2023, then decreased by 12.97% to $149.0 million in 2024, then plummeted by 47.37% to $78.4 million in 2025.
  • Business Quant data shows Total Current Liabilities for CDLX at $78.4 million in Q4 2025, $123.7 million in Q3 2025, and $129.1 million in Q2 2025.